EcoDrugPlus

Vascular Endothelial Growth Factor Ab

Ensembl ID : ENSNFUG00015004674
Gene Symbol: VEGFAB
1 Cross references
201 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSNFUG00015024414
Gene Symbol: VDR
3 Cross references
388 Possible Orthologues:

Vitamin D3 Receptor B-Like

Ensembl ID : ENSNFUG00015015702
Gene Symbol: LOC107385536
3 Cross references
392 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSNFUG00015011282
Gene Symbol: LOC107387978
3 Cross references
190 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-3-Like

Ensembl ID : ENSNFUG00015020935
Gene Symbol: LOC107391217
3 Cross references
196 Possible Orthologues:

Voltage-Dependent T-Type Calcium Channel Subunit Alpha-1i-Like

Ensembl ID : ENSNFUG00015000792
Gene Symbol: LOC107391375
2 Cross references
183 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-1 Subunit-Like

Ensembl ID : ENSNFUG00015012695
Gene Symbol: LOC107376577
3 Cross references
194 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-2 Subunit-Like

Ensembl ID : ENSNFUG00015004917
Gene Symbol: LOC107375153
3 Cross references
200 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSNFUG00015012702
Gene Symbol: LOC107376576
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-5 Subunit

Ensembl ID : ENSNFUG00015004899
Gene Symbol: LOC107391664
3 Cross references
184 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-5 Subunit-Like

Ensembl ID : ENSNFUG00015022833
Gene Symbol: LOC107376517
3 Cross references
169 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSNFUG00015011951
Gene Symbol: LOC107374607
2 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).